Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Javitt Daniel C., Executive. Insider active across 1 company, notably NRX Pharmaceuticals, Inc.. Cumulatively, 15 disclosures have been recorded. Split: 5 buys · 6 sells. Total volume traded: €7.2m. Activity tracked since 1 June 2022. The latest transaction was disclosed on 17 December 2024 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Javitt Daniel C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Daniel C. Javitt is an executive at NRX Pharmaceuticals, Inc. Although he does not have a specified function, he contributes to the direction and strategy of the company. His role is essential in guiding strategic decisions and ensuring NRX Pharmaceuticals' performance.